The Use of Vitamins and Coenzyme Q10 for the Treatment of Vascular Occlusion Diseases Affecting the Retina.

Abstract

Nutritional supplementation with antioxidants and vitamins is widely recommended in the treatment of vascular disorders affecting the retina, although there is insufficient evidence on its effectiveness. The vitamin-like compound coenzyme Q10 (CoQ10) is a nutritional supplement of current interest to treat neurodegenerative diseases. Here, we report a retrospective clinical case series study of 48 patients diagnosed with retinal vascular diseases, including non-arteritic ischemic optic neuropathy (NAION), retinal artery occlusion (RAO), and homonymous hemianopia or quadrantanopia following stroke, treated with oral supplementation with CoQ10 (100 mg per day) and vitamins. Patient follow-up was performed using the Humphrey field analyzer and 30-2 testing algorithm to determine the visual field index (VFI) and progression rates. All treated patients showed positive VFI progression rates per year: +11.5 ± 15% for NAION patients (n = 18), +22 ± 17% for RAO patients (n = 7), +9.3 ± 10.5% for hemianopia/quadrantanopia patients (n = 10), and +11 ± 21% for patients with other conditions (n = 13). The interruption of CoQ10 supplementation in one patient resulted in a pronounced decrease of the VFI, which was partially recovered when treatment was restored. This study supports the role of CoQ10 as a nutritional therapeutic agent for vascular diseases affecting the retina. Owing to decreased VFI after interruption of CoQ10, its beneficial effects may be reversible.

• Authors: Beatriz Fernández-Vega, Javier Nicieza, Ana Álvarez-Barrios, Lydia Álvarez, Montserrat García, Carlos Fernández-Vega, José A Vega, Héctor González-Iglesias
• Journal: Nutrients (Nutrients) Vol. 12 Issue 3 (Mar 09 2020) ISSN: 2072-6643 [Electronic] Switzerland
• PMID: 32182869 (Publication Type: Evaluation Study, Journal Article)

Chemical References

• Vitamins
• Ubiquinone
• coenzyme Q10

Topics

• Adult
• Aged
• Dietary Supplements
• Disease Progression
• Female
• Humans
• Male
• Middle Aged
• Retinal Artery Occlusion (therapy)
• Retinal Vein Occlusion (therapy)
• Retrospective Studies
• Treatment Outcome
• Ubiquinone (administration & dosage, analogs & derivatives)
• Visual Fields (drug effects)
• Vitamins (administration & dosage)